|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits in other banks | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Securities available-for-sale, at fair value (amortized cost of $337,681 and $265,371) | ||||||||||||||||||||
| Loans receivable held for investment, net of allowance of $10,799 and $9,424 | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Federal Home Loan Bank (“FHLB”) stock | ||||||||||||||||||||
| Federal Reserve Bank (“FRB”) stock | ||||||||||||||||||||
| Office properties and equipment, net | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Core deposit intangible, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| FHLB borrowings | ||||||||||||||||||||
| Bank Term Funding Program borrowing | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Borrowings | ||||||||||||||||||||
| Securities sold under agreements to repurchase | ||||||||||||||||||||
| Secured borrowings | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Preferred stock | ||||||||||||||||||||
| Non-Cumulative Redeemable Perpetual Preferred Stock, Series C | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| Class A Voting Common Stock | ||||||||||||||||||||
| Class B Non-Voting Common Stock | ||||||||||||||||||||
| Class C Non-Voting Common Stock | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Unearned Employee Stock Ownership Plan (“ESOP”) shares | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of tax | ||||||||||||||||||||
| Treasury stock-at cost, 327,228 shares at June 30, 2026 and at December 31, 2025 | ||||||||||||||||||||
| Total Broadway Financial Corporation and Subsidiary stockholders’ equity | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
